Anaphylaxis: intramuscular epinephrine may be absorbed faster than subcutaneous
|
|
The study
Single-blinded ?concealed randomised
trial
with
intention-to-treat
Setting: allergy laboratory, Canada
17 patients
(aged
mean 8,
?%
male)
well children with a history of severe allergies and systemic anaphylaxis, who carried injectable epinephrine at all times
Excluded if
- on other medication except inhaled or intranasal glucocorticoids
- refused venipuncture
- recent acute illness
- requiring oral or injected medication within previous month
- unable to discontinue beta-2-agonists for 24 hours before study or during the study
- weight < 15 kg, > 40 kg
- aged < 4 or > 12
Control Group: (n = 8, 8 analysed):
intramuscular
epinephrine
0.3 mg
Experimental Group: (n = 9, 9 analysed):
subcutaneous
epinephrine
0.01 mg/kg to a maximum of 0.3 mg
100% followed for
3
hours
The evidence
| Outcome |
Control Group (SD) |
Experimental Group (SD) |
Mean Difference (95% CI) |
| time to maximum epinephrine peak (minutes)
|
34
(40)
|
8
(6)
|
26
(-3 to 55)
|
Comments
- The study is too small to show any difference between the 2 groups.
- Children in the both groups received similar doses of epinephrine.
- Unclear whether these results apply to patients having an anaphylactic reaction.
Citation
-
Simons
FE,
Roberts
JR,
Gu
X, et al:
epinephrine absorption in children with a history of anaphylaxis.
Journal of Allergy and Clinical Immunology
1998;
101:
33-37
Search Terms:
anaphyla* in Cochrane
Contributor: Mike Bennett and Chris Ball,
November 1999
Reviewer: Chris Ball
Clinical Question.
| Patient |
anaphylaxis |
| Intervention or Exposure |
intramuscular epinephrine |
| Comparison |
subcutaneous epinephrine |
| Outcome |
absorption rates |
|
|